Co-Founder, Chairman & CEO
Marc Tessier-Lavigne is co-founder, Chairman & CEO of Xaira Therapeutics. Previously, he held executive positions at Genentech, where he was chief scientific officer, and in academia, where he served as president of The Rockefeller University and of Stanford University, where he remains professor of Biology. He also served previously on the faculty of the University of California, San Francisco, and was an investigator with the Howard Hughes Medical Institute. A Rhodes Scholar, Dr. Tessier-Lavigne has been a leader in understanding mechanisms that direct brain wiring. He has received numerous scientific awards, including the 2020 Gruber Neuroscience Prize, and has been elected to multiple scientific societies, including the US National Academy of Sciences and US National Academy of Medicine; he is also an Officer of the Order of Canada. Dr. Tessier-Lavigne has co-founded two neuroscience startups, Renovis and Denali, and served on the boards of Agios, Regeneron, Pfizer, Juno and Denali.